NOT KNOWN DETAILS ABOUT MAKATUSSIN SYROP

mavorixafor will improve the stage or outcome of codeine by impacting hepatic enzyme CYP2D6 metabolism. Contraindicated. Mavorixafor (a robust CYP2D6 inhibitor) is contraindicated with medicine which are extremely dependent on CYP2D6 for clearance.Responses on the session recognized the tension pharmacists had been under to supply the medication to